Compare KURA & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | NTB |
|---|---|---|
| Founded | 2014 | 1858 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 2.1B |
| IPO Year | N/A | 2016 |
| Metric | KURA | NTB |
|---|---|---|
| Price | $10.38 | $49.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $25.00 | ★ $50.67 |
| AVG Volume (30 Days) | ★ 1.7M | 148.7K |
| Earning Date | 11-04-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 4.01% |
| EPS Growth | N/A | ★ 17.07 |
| EPS | N/A | ★ 5.27 |
| Revenue | $104,029,000.00 | ★ $599,452,000.00 |
| Revenue This Year | $138.16 | $4.72 |
| Revenue Next Year | $66.98 | N/A |
| P/E Ratio | ★ N/A | $9.46 |
| Revenue Growth | N/A | ★ 4.60 |
| 52 Week Low | $5.41 | $34.77 |
| 52 Week High | $12.49 | $52.11 |
| Indicator | KURA | NTB |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 56.43 |
| Support Level | $9.68 | $50.50 |
| Resistance Level | $11.28 | $52.11 |
| Average True Range (ATR) | 0.49 | 0.78 |
| MACD | -0.05 | -0.31 |
| Stochastic Oscillator | 42.50 | 11.95 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.